Recruitment

Recruitment Status
Active, not recruiting
Estimated Enrollment
120

Summary

Conditions
"Attention Deficit Hyperactivity Disorder"
Type
Interventional
Phase
Phase 1Phase 2
Design
Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)Masking Description: Placebo-controlled; randomization created by statistician, all involved in the study and assessment are blindedPrimary Purpose: Treatment

Participation Requirements

Age
Between 6 years and 12 years
Gender
Both males and females

Description

This study examines a broad spectrum micronutrient treatment for children with ADHD. The goal is to broaden the scope of evidence-based treatments, and to address the public desire for non-pharmacological treatment options. This study will use a randomized controlled trial design, comparing micronut...

This study examines a broad spectrum micronutrient treatment for children with ADHD. The goal is to broaden the scope of evidence-based treatments, and to address the public desire for non-pharmacological treatment options. This study will use a randomized controlled trial design, comparing micronutrients with placebo in 135 children, ages 6-12, with ADHD plus irritability or anger based on parent-report of symptoms. The study will also collect biological samples (saliva, stool, urine, hair, and blood) from the children to examine physiological mechanisms of micronutrient effects. If the micronutrient treatment successfully diminishes symptoms, the clinical implication is to offer this as a legitimate non-pharmacological alternative to stimulant medication.

Tracking Information

NCT #
NCT03252522
Collaborators
  • Ohio State University
  • University of Lethbridge
Investigators
Principal Investigator: Jeanette Johnstone Oregon Health and Science University